Emma L. Houlder

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Temporal modulation of gene expression in a controlled Schistosoma mansoni human infection model.

Temporal modulation of gene expression in a controlled Schistosoma mansoni human infection model.

Journal: Frontiers in immunology
Published: September 17, 2025

Intradermal immunization with Plasmodium berghei late-arresting genetically attenuated sporozoites induces PD-L1 expression on regulatory macrophages and dendritic cells.

Intradermal immunization with Plasmodium berghei late-arresting genetically attenuated sporozoites induces PD-L1 expression on regulatory macrophages and dendritic cells.

Journal: Scientific reports
Published: June 02, 2025

Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review.

Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review.

Journal: PLoS neglected tropical diseases
Published: February 28, 2025

T cell responses in repeated controlled human schistosome infection compared to natural exposure.

T cell responses in repeated controlled human schistosome infection compared to natural exposure.

Journal: Nature communications
Published: February 20, 2025

Early Activation of Lung CD8+ T Cells After Immunization with Live Plasmodium berghei Malaria Sporozoites.

Early Activation of Lung CD8+ T Cells After Immunization with Live Plasmodium berghei Malaria Sporozoites.

Journal: Pathogens & immunity
Published: January 06, 2025

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.

Journal: The New England journal of medicine
Published: November 20, 2024

Global diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets.

Global diversity of soil-transmitted helminths reveals population-biased genetic variation that impacts diagnostic targets.

Journal: Nature communications
Published: September 23, 2024

Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection.

Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection.

Journal: The Journal of clinical investigation
Published: July 30, 2024

Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection.

Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection.

Journal: Science immunology
Published: July 05, 2024

Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype.

Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype.

Journal: The Journal of allergy and clinical immunology
Published: March 06, 2024

Mgl2+ cDC2s coordinate fungal allergic airway type 2, but not type 17, inflammation in mice.

Mgl2+ cDC2s coordinate fungal allergic airway type 2, but not type 17, inflammation in mice.

Journal: Nature communications
Published: January 02, 2024

Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection study.

Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection study.

Journal: EBioMedicine
Published: July 18, 2023
Showing 1-12 of 17

Last Updated: 09/26/2026